Ventana Medical Systems
David Roberts has extensive experience in the field of chemistry and biotechnology, currently serving as a Project Lead at Roche since October 2011, focusing on Companion Diagnostics. Previously, David held positions as a Technical Supervisor, leading the New Product Transfer group in Reagent Operations, and as a Senior Scientist and Scientist at Ventana Research Corporation, managing key research projects. David's earlier roles include an Analytical Chemistry internship at GlaxoSmithKline, where research improved protein sequencing efficiency, a product testing internship at Kimberly-Clark addressing adhesive failures, and a research internship at the National Institute of Environmental Health Sciences focused on developing a new screening assay for oxidative mutations. David holds a Ph.D. in Chemistry from the University of Arizona and a BS in Chemistry from the University of North Carolina at Chapel Hill.
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.